Ocular Therapeutix (OCUL) Prepaid Assets (2013 - 2026)
Ocular Therapeutix's quarterly Prepaid Assets came in at $11.2 million in Q1 2026, up 17.74% year-on-year from $9.5 million in Q1 2025, and up 3.29% quarter-over-quarter from $10.9 million in Q4 2025.
Ocular Therapeutix has reported Prepaid Assets for 14 years, with the latest figure at $11.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 17.74% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (up 17.74% YoY), and the FY2025 full-year result was $10.9 million, down 19.34% from the prior year.
- Prepaid Assets for Q1 2026 stood at $11.2 million, up from $10.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $13.5 million in Q4 2024, with the low at $3.3 million in Q3 2022.
- Average Prepaid Assets over 5 years is $7.4 million, with a median of $7.7 million recorded in 2024.
- Year-over-year, Prepaid Assets surged 170.49% in 2024 and tumbled 39.53% in 2025.
- Tracing OCUL's Prepaid Assets over 5 years: stood at $4.0 million in 2022, then surged by 93.5% to $7.8 million in 2023, then surged by 72.66% to $13.5 million in 2024, then slipped by 19.34% to $10.9 million in 2025, then advanced by 3.29% to $11.2 million in 2026.
- The last three Prepaid Assets figures came in at $11.2 million (Q1 2026), $10.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.21 Mn |
| Dec 31, 2025 | 10.86 Mn |
| Sep 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 8.79 Mn |
| Mar 31, 2025 | 9.52 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 13.15 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.67 Mn |
| Dec 31, 2023 | 7.79 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.67 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 4.82 Mn |
| Mar 31, 2021 | 4.00 Mn |
| Dec 31, 2020 | 4.65 Mn |
| Sep 30, 2020 | 2.33 Mn |
| Jun 30, 2020 | 2.06 Mn |
| Mar 31, 2020 | 2.47 Mn |
| Dec 31, 2019 | 2.23 Mn |
| Sep 30, 2019 | 2.21 Mn |
| Jun 30, 2019 | 2.29 Mn |
| Mar 31, 2019 | 2.38 Mn |
| Dec 31, 2018 | 1.71 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.22 Mn |
| Mar 31, 2018 | 1.26 Mn |
| Dec 31, 2017 | 1.45 Mn |
| Sep 30, 2017 | 883,000.00 |
| Jun 30, 2017 | 1.98 Mn |
| Mar 31, 2017 | 2.56 Mn |
| Dec 31, 2016 | 1.39 Mn |
| Sep 30, 2016 | 708,000.00 |
| Jun 30, 2016 | 715,000.00 |
| Mar 31, 2016 | 1.29 Mn |
| Dec 31, 2015 | 1.59 Mn |
| Sep 30, 2015 | 1.92 Mn |
| Jun 30, 2015 | 2.61 Mn |
| Mar 31, 2015 | 1.54 Mn |
| Dec 31, 2014 | 893,000.00 |
| Sep 30, 2014 | 1.21 Mn |
| Jun 30, 2014 | 283,000.00 |
| Dec 31, 2013 | 240,000.00 |